IL17A and arthropathy: By contrast, IL-17 inhibitors, while highly effective for psoriatic skin and joint disease, have been more frequently linked to cutaneous lupus manifestations, particularly in patients with SCLE/DLE or interferon-high phenotypes [9,20,26,27,28,29,30,31].